GovChime
Notice ID: b4fb180ef4044075b8ddf6c53c722d1dAward NoticeAwarded

Gene Therapy Resource Program (GTRP)

Awarded on December 19, 2018. Full description on SAM.gov.

Awarded tounder 75N92019D00017 (source: SAM.gov award notice)• $13.3M

Overview

Posted
December 21, 2018
Notice type
Award Notice
NAICS
541714: Research and Development in Biotechnology (except Nanobiotechnology)

Notice details

PSC
A: RESEARCH AND DEVELOPMENT
Last updated
Dec 6, 2025
Award date
Dec 19, 2018
Award amount (SAM.gov award notice)
$13.3M

Identifiers

Solicitation number
HHSN26818HV00005R
Notice ID
b4fb180ef4044075b8ddf6c53c722d1d
Award number (PIID)
75N92019D00017

Description

The NHLBI requires the Gene Therapy Resource Program (GTRP) support translational gene therapy research by providing resources and services from three core laboratories: 1.) Pharmacology and Toxicology Core Laboratory, 2.) Preclinical Vector Core Laboratory, 3.) Clinical Coordinating Center (CCC), which is not required to have any laboratory capabilities.

Full description on SAM.gov

Award Overview

Award Number

75N92019D00017

Award Amount (SAM.gov award notice)

$13.3M

Award Date

Dec 19, 2018

Awardee

Awardee UEI

MBT9RXJJ7428

Original Solicitation

Notice ID: b4fb180ef4044075b8ddf6c53c722d1d

Posted Date: Dec 21, 2018

Original Response Deadline: Not specified

Contract Details

No FPDS record matches this award number at the same department yet

Contract details typically appear within 2-4 weeks after award; DoD awards are published about 90 days after signature.

Task Orders Under This IDV

Top 10 by total obligated

10
  • 75N92021F00001
    LOVELACE BIOMEDICAL RESEARCH INSTITUTE
    Department of Health and Human ServicesNAICS 541714
    $1.6MSigned Jul 18, 2024
  • 75N92021F00001
    LOVELACE BIOMEDICAL RESEARCH INSTITUTE
    Department of Health and Human ServicesNAICS 541714
    $1.6MSigned Mar 29, 2024
  • 75N92021F00001
    LOVELACE BIOMEDICAL RESEARCH INSTITUTE
    Department of Health and Human ServicesNAICS 541714
    $1.6MSigned Sep 7, 2023
  • 75N92021F00001
    LOVELACE BIOMEDICAL RESEARCH INSTITUTE
    Department of Health and Human ServicesNAICS 541714
    $1.6MSigned Dec 18, 2023
  • 75N92021F00001
    LOVELACE BIOMEDICAL RESEARCH INSTITUTE
    Department of Health and Human ServicesNAICS 541714
    $1.6MSigned May 20, 2025
  • 75N92021F00001
    LOVELACE BIOMEDICAL AND ENVIRONMENTAL RESEARCH INSTITUTE, INC.
    Department of Health and Human ServicesNAICS 541714
    $1.6MSigned Sep 3, 2021
  • 75N92019F00074
    LOVELACE BIOMEDICAL RESEARCH INSTITUTE
    Department of Health and Human ServicesNAICS 541714
    $1.3MSigned Dec 16, 2022
  • 75N92022F00001
    LOVELACE BIOMEDICAL RESEARCH INSTITUTE
    Department of Health and Human ServicesNAICS 541714
    $1.3MSigned Jul 18, 2024
  • 75N92022F00001
    LOVELACE BIOMEDICAL RESEARCH INSTITUTE
    Department of Health and Human ServicesNAICS 541714
    $1.3MSigned Mar 29, 2024
  • 75N92022F00001
    LOVELACE BIOMEDICAL RESEARCH INSTITUTE
    Department of Health and Human ServicesNAICS 541714
    $1.3MSigned Dec 18, 2023

More From This Vendor

Top 5 most recent

5
  • 75A50123F61001
    LOVELACE BIOMEDICAL RESEARCH INSTITUTE
    Department of Health and Human ServicesNAICS 541714
    $100.3KSigned Nov 5, 2026
  • 75A50122D00021
    LOVELACE BIOMEDICAL RESEARCH INSTITUTE
    Department of Health and Human ServicesNAICS 541714
    $75.0KSigned Nov 5, 2026
  • 75N98026F00001
    LOVELACE BIOMEDICAL RESEARCH INSTITUTE
    Department of Health and Human ServicesNAICS 541714
    $339.5KSigned Sep 25, 2026
  • 75N93021F00001
    LOVELACE BIOMEDICAL RESEARCH INSTITUTE
    Department of Health and Human ServicesNAICS 541714
    —Signed Sep 15, 2026
  • 75A50126F61002
    LOVELACE BIOMEDICAL RESEARCH INSTITUTE
    Department of Health and Human ServicesNAICS 541714
    $3.7MSigned Aug 21, 2026

Contacts

Documents

No documents available.

Lifecycle

Solicitation:HHSN26818HV00005R
  1. Pre-Solicitation
  2. Solicitation
  3. Awarded

This opportunity has been awarded.

  1. 5×
    Pre-SolicitationSep 19, 2017

    A--Gene Therapy Resource Program (GTRP)

    Notice 74eafe4904086e83f3fb791343f4933e on SAM.gov

  2. SolicitationFeb 6, 2018

    A--Gene Therapy Resource Program (GTRP)

    Notice 2abbf8686dd01904162199e2424ddb37 on SAM.gov

  3. 3×
    AwardedCurrentDec 19, 2018

    Gene Therapy Resource Program (GTRP)

    Notice b4fb180ef4044075b8ddf6c53c722d1d on SAM.gov

Similar Opportunities

Title
Match
Phase
Deadline
Amendment 0001 to this notice is to push out the anticipated posting of the solicitation to late November 2026. This is a pre-solicitation notice to synopsize the intention of the Defense Health Agency Contracting Activity (DHACA) to issue a Request for Proposal (RFP) for an on-ramp to the OMNIBUS IV Multiple Award, Indefinite Delivery, Indefinite Quantity (IDIQ) contract vehicle covering military medical research and development services. A historical pre-solicitation notice was posted under Notice ID# HT942626RE002, although there were various delays with getting a solicitation out in Fiscal Year 2026. This notice is taking over where Notice ID# HT942626RE002 left off. No further delays are anticipated at this time for this on-ramp. The eventual RFP will be set-aside for small businesses certified under the Small Business Administration 8(a) Program. The Government anticipates making multiple new awards under this on-ramp, and all new awards will align with the existing unrestricted contract vehicle. This notice is not a request for proposals and does not commit the Government to any contractual agreement. The OMNIBUS IV contract vehicle was awarded under full and open competition with a base ordering period of 20 June 2022 through 19 June 2027 and an Option Ordering Period of 20 June 2027 - 19 June 2032. Task orders may be competed under fair opportunity (providing all Contract Holders within a Market Segment the opportunity to submit a proposal) or an exception to fair opportunity (such as set-asides for small businesses or applicable small business socioeconomic categories). The cumulative ceiling of this unrestricted IDIQ contract vehicle is $10 billion. To date, the accumulated awarded task order value (including future unexercised option periods) is over $690 million across 61 task orders. Task Orders have been issued by a growing number of end users including DHACA, the U.S. Army Medical Research Acquisition Activity (now integrated into DHACA), the Naval Supply Systems Command, and the Uniformed Services University of the Health Sciences. When excluding the task orders simply providing a minimum guarantee to the existing Contract Holders, 61 task orders have been issued off this contract vehicle with 8 task orders being set aside for the 8(a) Program and 15 task orders being awarded to an 8(a) Participant (based on the most recent representations at the contract level). 42 task orders have been awarded so far to small businesses under this contract vehicle. Of the 61 task orders, 95% were awarded during the Government Fiscal Years 2024 - 2026. Please see attachments for further details.
-Pre-SolicitationOpen
Please see attached Sources Sought. Questions & Answers attached.
-Market Research11/12/2026
UPDATE: The purpose of Amendment 1 to DARPA-PA-26-137, the Firefox Program Solicitation (PS), is to update the deadlines for OPP submissions and presentations. The Defense Advanced Research Projects Agency (DARPA) has developed a non-invasive coherent optical system capable of recording neural signals in humans. To expand this foundational technology and enable the development of revolutionary, non-invasive brain-computer interfaces (BCIs), DARPA's Firefox program is soliciting approaches to overcome key technological hurdles: 1) development of components enabling dynamic rastering/scanning of the incoming coherent optical signal to target multiple regions of interest and 2) development of new data processing architectures beyond the digital domain to handle the high data rates and computational burden inherent to scaling the amount of neural data recorded by the optical system. The ultimate goal of the Firefox program is to use these innovations to develop a 100-channel, non-invasive BCI with 50-micron spatial and 100-microsecond temporal resolution.
-Solicitation11/30/2026
The purpose of this Special Notice (SN) is to provide public notification of additional research areas of interest to the Defense Advanced Research Projects Agency (DARPA) Biological Technologies Office (BTO), specifically for the forthcoming Laguna program. When released, the solicitation will be made available at https://sam.gov/. Additionally, this SN may be amended with a draft solicitation when available.
-Special Notice11/30/2026
PLEASE SEE THE ATTACHED DOCUMENTS FOR DETAILS. QUOTES WILL NOT BE REVIEWED OR ACCEPTED. IF YOU FEEL YOUR COMPANY CAN PROVIDE THIS SERVICE, SUBMIT A CAPABILITY STATEMENT.
-Special Notice11/09/2026

Additional Details

Solicitation Number

HHSN26818HV00005R

Archive Date

Jan 3, 2019